Drug recall · December 5, 2018
Quetiapine Tablets USP 400 mg recall
Why: Presence of Foreign Substance; metal shard found in tablet
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1
- Lots / codes
Lot 7143908, exp Nov 2020
- Quantity
- N/A
- Company
- Ascend Laboratories LLC, Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- November 14, 2018 · Voluntary: Firm initiated
- Classified
- November 28, 2018
- Reported
- December 5, 2018
- Ended
- March 30, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Quetiapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.